HIMS: Regulatory Arbitrage and the Future of Personalized Medicine This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Buy BPC 157 Peptides (10MG) 99% Pure RUO Peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru